Cardiostimulatory effects of oxyfedrine, DMPP and sympathomimetics in relation to their3H-noradrenaline-releasing properties

  • W. R. Kukovetz
  • G. Pöch


The effect of noradrenaline, norephedrine, oxyfedrine and DMPP on isotonic contractions and release of3H-noradrenaline was studied using isolated perfused guinea-pig hearts.

The spontaneous rate of3H-release was linear from 30–70 min after infusion of a tracer dose of 20 ΜCi noradrenaline. The calculated size of the labeled noradrenaline-pool of the heart was 5–10% of the total noradrenaline-content.

Oxyfedrine (10 Μg) caused strong and long lasting positive inotropic effects but only a weak and transient increase of3H-release. Equimolar doses of 5Μg 1-norephedrine which is a component of the oxyfedrine molecule had no significant inotropic effect but caused similar increases in3H-release.

Noradrenaline (0.5 Μg, a dose with maximum positive inotropic action) released more3H-activity from the heart than oxyfedrine.

DMPP, a ganglion stimulating agent, in doses of 250 Μg, increased contractions significantly but had very little effect on3H-noradrenaline-release. An additional release of non-labeled noradrenaline is discussed as explanation of the positive inotropic action of DMPP.

After repeated administration of DMPP in large doses, the increase in contraction and3H-release was abolished. In this state of tachyphylaxis oxyfedrine also failed to release3H-noradrenaline but retained its full inotropic effect.

The results do not provide evidence that a releasing effect on labeled and/or non-labeled endogenous noradrenaline significantly contributes to the positive inotropic action of oxyfedrine. This finding supports the view that oxyfedrine stimulates the heart by adirect action on sympatheticΒ-receptors.


Guinea-Pig Heart 3H-Noradrenaline-Release Contraction Sympathomimetics Oxyfedrine 


Meerschweinchenherz 3H-Noradrenalinfreisetzung Kontraktion Sympathomimetica Oxyfedrin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andén, N.-E., Magnusson, T.: Functional significance of noradrenaline depletion byα-methyl metatyrosine, metaraminol and dextro-adrenaline. In “Pharmacology of Cholinergic and Adrenergic Transmission”. Proc. 2nd Int. Pharmacol. Meeting, vol. 3, pp. 319–328. Oxford: Pergamon Press 1965.Google Scholar
  2. Chen, G., Portman, R., Wickel, A.: Pharmacology of 1,1-dimethyl-4-phenyl-piperazinium iodide, a ganglionic stimulating agent. J. Pharmacol. exp. Ther.103, 330 (1951).Google Scholar
  3. Crout, J. R., Muskus, A. J., Trendelenburg, U.: Effect of tyramine on isolated guinea-pig atria in relation to their noradrenaline stores. Brit. J. Pharmacol.18, 600–611 (1962).Google Scholar
  4. Farnebo, L.-O., Malmfors, T.: Histochemical studies on the uptake of noradrenaline andα-methyl-noradrenaline in the perfused rat heart. Europ. J. Pharmacol.5, 313–320 (1969).Google Scholar
  5. Huković, S., Muscholl, E.: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.244, 81–96 (1962).Google Scholar
  6. Iversen, L. L.: The uptake and storage of noradrenaline in sympathetic nerves. Cambridge: University Press 1967.Google Scholar
  7. Kopin, I. J.: Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings. Pharmacol. Rev.18, 513–523 (1966).Google Scholar
  8. —, Hertting, G., Gordon, E.: Fate of norepinephrine-3H in the isolated perfused rat heart. J. Pharmacol. exp. Ther.138, 34–40 (1962).Google Scholar
  9. Kukovetz, W. R.: KontraktilitÄt und PhosphorylaseaktivitÄt des Herzens bei ganglionÄrer Erregung nach adrenerger Blockade und unter Atropin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.243, 391–406 (1962).Google Scholar
  10. —, Pöch, G.: Beta-adrenerge Effekte und ihr zeitlicher Verlauf unter Tetrahydropapaverolin und Isoprenalin am Langendorff-Herzen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.256, 301–309 (1967a).Google Scholar
  11. — —: The action of imidazole on the effects of methylxanthines and catecholamines on cardiac contraction and phosphorylase activity. J. Pharmacol. exp. Ther.156, 514–521 (1967b).Google Scholar
  12. — —: Erregung adrenerger Beta-Rezeptoren in den Herzen normaler und reserpinisierter Meerschweinchen durch Oxyfedrin. Arzneimittel-Forsch. (Drug Res.)19, 1562–1566 (1969).Google Scholar
  13. Lindmar, R., Muscholl, E.: Die Wirkung von Cocain, Guanethidin, Reserpin, Hexamethonium, Tetracain und Psicain auf die Noradrenalin-Freisetzung aus dem Herzen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.242, 214–227 (1961).Google Scholar
  14. Muscholl, E.: Indirectly acting sympathomimetic amines. Pharmacol. Rev.18, 551–559 (1966).Google Scholar
  15. Nash, C. W., Wolff, S. A., Ferguson, B. A.: Release of tritiated noradrenaline from perfused rat hearts by sympathomimetic amines. Canad. J. Physiol. Pharmacol.46, 35–42 (1968).Google Scholar
  16. Reiter, M.: Die Wirkung des Oxyfedrin auf KontraktilitÄt und Erregungsvorgang des isolierten Meerschweinchenpapillarmuskels. Paper presented at the “Symposion über die Kardio-energetische Koronartherapie mit Oxyfedrin“, May 22, 1968, at Regensburg (B.R.D.).Google Scholar
  17. Schümann, H.-J.: Einflu\ von Oxyfedrin auf die Brenzkatechinaminfreisetzung und -aufnahme in Meerschweinchenherzen. Paper presented at the „Symposion über die Kardio-energetische Koronartherapie mit Oxyfedrin“, May 22, 1968, at Regensburg (B.R.D.).Google Scholar
  18. Shahab, L., Wollenberger, E.: Freisetzung von Noradrenalin aus dem isoliert durch-strömten Herzen bei akuter Anoxie und nach Gabe von Stoffwechselgiften. Acta biol. med. germ.19, 939–959 (1967).Google Scholar
  19. Stroman, F., Habersang, S.: Ergebnisse der pharmakologischen Prüfung des Oxyfedrin. Paper presented at the „Symposion über die Kardio-energetische Koronartherapie mit Oxyfedrin“, May 22, 1968, at Regensburg (B.R.D.).Google Scholar
  20. Thiemer, K.: Zur Biochemie von Oxyfedrin. Paper presented at the „Symposion über die Kardio-energetische Koronartherapie mit Oxyfedrin“, May 22, 1968, at Regensburg (B.R.D.).Google Scholar
  21. Trendelenburg, U.: Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev.15, 225–276 (1963).Google Scholar
  22. —, Muskus, A., Fleming, W. W., Gomez Alonso de la Sierra, B.: Modification by reserpine of the action of sympathomimetic amines in spinal cats; a classification of sympathomimetic amines. J. Pharmacol. exp. Ther.138, 170–180 (1962).Google Scholar

Copyright information

© Springer-Verlag 1971

Authors and Affiliations

  • W. R. Kukovetz
    • 1
  • G. Pöch
    • 1
  1. 1.Department of PharmacologyUniversity of GrazAustria

Personalised recommendations